Tiffany E. Kaiser

969 total citations
9 papers, 778 citations indexed

About

Tiffany E. Kaiser is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Tiffany E. Kaiser has authored 9 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Hepatology and 2 papers in Infectious Diseases. Recurrent topics in Tiffany E. Kaiser's work include Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (4 papers) and Liver Disease and Transplantation (2 papers). Tiffany E. Kaiser is often cited by papers focused on Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (4 papers) and Liver Disease and Transplantation (2 papers). Tiffany E. Kaiser collaborates with scholars based in United States and Germany. Tiffany E. Kaiser's co-authors include Martin Sarter, Jill McGaughy, Kenneth E. Sherman, Mark H. Eckman, Nyingi Kemmer, Guy Neff, Joseph F. Buell, Mark Thomas, David M. Novick and Mark Jonas and has published in prestigious journals such as Clinical Infectious Diseases, Annals of Surgery and Science Advances.

In The Last Decade

Tiffany E. Kaiser

8 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tiffany E. Kaiser United States	7	454	350	258	148	146	9	778
François Laplante Canada	15	294 0.6×	476 1.4×	236 0.9×	19 0.1×	6 0.0×	22	696
Jessica Strömberg Sweden	9	34 0.1×	160 0.5×	60 0.2×	35 0.2×	38 0.3×	11	596
Tracy L. Fetterly United States	10	97 0.2×	212 0.6×	82 0.3×	29 0.2×	7 0.0×	12	379
Gianna Ragagnin Sweden	6	35 0.1×	99 0.3×	38 0.1×	32 0.2×	38 0.3×	9	392
Andrea M. Robinson United States	11	67 0.1×	163 0.5×	32 0.1×	36 0.2×	20 0.1×	21	305
Corinne Staner France	11	300 0.7×	56 0.2×	69 0.3×	30 0.2×	9 0.1×	12	508
Wenjie Zhou China	12	98 0.2×	156 0.4×	102 0.4×	9 0.1×	6 0.0×	19	439
Ora Keren Israel	16	102 0.2×	387 1.1×	219 0.8×	17 0.1×	3 0.0×	32	585
Isabel Cristina Céspedes Brazil	13	66 0.1×	116 0.3×	55 0.2×	22 0.1×	7 0.0×	44	501
Chen Su China	9	98 0.2×	179 0.5×	133 0.5×	12 0.1×	3 0.0×	15	463

Countries citing papers authored by Tiffany E. Kaiser

Since Specialization

Citations

This map shows the geographic impact of Tiffany E. Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiffany E. Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiffany E. Kaiser more than expected).

Fields of papers citing papers by Tiffany E. Kaiser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiffany E. Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiffany E. Kaiser. The network helps show where Tiffany E. Kaiser may publish in the future.

Co-authorship network of co-authors of Tiffany E. Kaiser

This figure shows the co-authorship network connecting the top 25 collaborators of Tiffany E. Kaiser. A scholar is included among the top collaborators of Tiffany E. Kaiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiffany E. Kaiser. Tiffany E. Kaiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Kaiser, Tiffany E., Herwig Koppensteiner, Baubak Bajoghli, et al.. (2025). HIV-1 manipulates CD96 on CD4 ⁺ T cells to subvert antiviral immunity. Science Advances. 11(36). eadx7485–eadx7485.

2.

Delman, Aaron M., Kevin M. Turner, Kamran Safdar, et al.. (2021). Expanding the Donor Pool: First Use of Hepatitis B Virus Nat Positive Solid Organ Allografts Into Seronegative Recipients. Annals of Surgery. 274(4). 556–564. 16 indexed citations

3.

Neff, Guy, Michael Jones, Mark Jonas, et al.. (2013). Lack of Clostridium difficile Infection in Patients Treated With Rifaximin for Hepatic Encephalopathy. Journal of Clinical Gastroenterology. 47(2). 188–192. 22 indexed citations

4.

Eckman, Mark H., Tiffany E. Kaiser, & Kenneth E. Sherman. (2011). The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United States. Clinical Infectious Diseases. 52(11). 1294–1306. 61 indexed citations

5.

Neff, Guy, Michael Jones, Taylor Broda, et al.. (2011). Durability of Rifaximin Response in Hepatic Encephalopathy. Journal of Clinical Gastroenterology. 46(2). 168–171. 23 indexed citations

6.

Neff, Guy, et al.. (2007). Combination Therapy in Liver Transplant Recipients with Hepatitis B Virus Without Hepatitis B Immune Globulin. Digestive Diseases and Sciences. 52(10). 2497–2500. 40 indexed citations

7.

Neff, Guy, Ernst Weber, Tiffany E. Kaiser, et al.. (2006). 505 Conversion of liver transplant recipients with hepatitis B virus from hepatitis B immune globulin (HBIG) and lamivudine (LAM) to adefovir dipivoxil (ADV) and LAM. Journal of Hepatology. 44. S188–S188. 1 indexed citations

8.

McGaughy, Jill, Tiffany E. Kaiser, & Martin Sarter. (1996). Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: Selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density.. Behavioral Neuroscience. 110(2). 247–265. 285 indexed citations

9.

McGaughy, Jill, Tiffany E. Kaiser, & Martin Sarter. (1996). Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: Selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density.. Behavioral Neuroscience. 110(2). 247–265. 330 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact